348 related articles for article (PubMed ID: 29108094)
1. Dimethyl fumarate treatment alters NK cell function in multiple sclerosis.
Smith MD; Calabresi PA; Bhargava P
Eur J Immunol; 2018 Feb; 48(2):380-383. PubMed ID: 29108094
[TBL] [Abstract][Full Text] [Related]
2. Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients.
Longbrake EE; Ramsbottom MJ; Cantoni C; Ghezzi L; Cross AH; Piccio L
Mult Scler; 2016 Jul; 22(8):1061-1070. PubMed ID: 26459150
[TBL] [Abstract][Full Text] [Related]
3. Monomethyl fumarate augments NK cell lysis of tumor cells through degranulation and the upregulation of NKp46 and CD107a.
Vego H; Sand KL; Høglund RA; Fallang LE; Gundersen G; Holmøy T; Maghazachi AA
Cell Mol Immunol; 2016 Jan; 13(1):57-64. PubMed ID: 25435072
[TBL] [Abstract][Full Text] [Related]
4. Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study.
Marastoni D; Buriani A; Pisani AI; Crescenzo F; Zuco C; Fortinguerra S; Sorrenti V; Marenda B; Romualdi C; Magliozzi R; Monaco S; Calabrese M
Front Immunol; 2019; 10():1666. PubMed ID: 31379857
[No Abstract] [Full Text] [Related]
5. Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS.
Fleischer V; Friedrich M; Rezk A; Bühler U; Witsch E; Uphaus T; Bittner S; Groppa S; Tackenberg B; Bar-Or A; Zipp F; Luessi F
Mult Scler; 2018 Apr; 24(5):632-641. PubMed ID: 28436295
[TBL] [Abstract][Full Text] [Related]
6. IL-17
Lückel C; Picard F; Raifer H; Campos Carrascosa L; Guralnik A; Zhang Y; Klein M; Bittner S; Steffen F; Moos S; Marini F; Gloury R; Kurschus FC; Chao YY; Bertrams W; Sexl V; Schmeck B; Bonetti L; Grusdat M; Lohoff M; Zielinski CE; Zipp F; Kallies A; Brenner D; Berger M; Bopp T; Tackenberg B; Huber M
Nat Commun; 2019 Dec; 10(1):5722. PubMed ID: 31844089
[TBL] [Abstract][Full Text] [Related]
7. Dimethyl fumarate influences innate and adaptive immunity in multiple sclerosis.
Diebold M; Sievers C; Bantug G; Sanderson N; Kappos L; Kuhle J; Lindberg RLP; Derfuss T
J Autoimmun; 2018 Jan; 86():39-50. PubMed ID: 28958667
[TBL] [Abstract][Full Text] [Related]
8. Dimethyl fumarate downregulates the immune response through the HCA
von Glehn F; Dias-Carneiro RPC; Moraes AS; Farias AS; Silva VAPG; Oliveira FTM; Silva CEBG; de Carvalho F; Rahal E; Baecher-Allan C; Santos LMB
Mult Scler Relat Disord; 2018 Jul; 23():46-50. PubMed ID: 29763776
[TBL] [Abstract][Full Text] [Related]
9. Dimethyl fumarate: Regulatory effects on the immune system in the treatment of multiple sclerosis.
Hosseini A; Masjedi A; Baradaran B; Hojjat-Farsangi M; Ghalamfarsa G; Anvari E; Jadidi-Niaragh F
J Cell Physiol; 2019 Jul; 234(7):9943-9955. PubMed ID: 30536402
[TBL] [Abstract][Full Text] [Related]
10. Dimethyl fumarate impairs differentiated B cells and fosters central nervous system integrity in treatment of multiple sclerosis.
Traub J; Traffehn S; Ochs J; Häusser-Kinzel S; Stephan S; Scannevin R; Brück W; Metz I; Weber MS
Brain Pathol; 2019 Sep; 29(5):640-657. PubMed ID: 30706542
[TBL] [Abstract][Full Text] [Related]
11. Optimal response to dimethyl fumarate is mediated by a reduction of Th1-like Th17 cells after 3 months of treatment.
Mansilla MJ; Navarro-Barriuso J; Presas-Rodríguez S; Teniente-Serra A; Quirant-Sánchez B; Ramo-Tello C; Martínez-Cáceres EM
CNS Neurosci Ther; 2019 Sep; 25(9):995-1005. PubMed ID: 31066225
[TBL] [Abstract][Full Text] [Related]
12. Dimethyl fumarate treatment restrains the antioxidative capacity of T cells to control autoimmunity.
Liebmann M; Korn L; Janoschka C; Albrecht S; Lauks S; Herrmann AM; Schulte-Mecklenbeck A; Schwab N; Schneider-Hohendorf T; Eveslage M; Wildemann B; Luessi F; Schmidt S; Diebold M; Bittner S; Gross CC; Kovac S; Zipp F; Derfuss T; Kuhlmann T; König S; Meuth SG; Wiendl H; Klotz L
Brain; 2021 Nov; 144(10):3126-3141. PubMed ID: 34849598
[TBL] [Abstract][Full Text] [Related]
13. Dimethyl fumarate induces a persistent change in the composition of the innate and adaptive immune system in multiple sclerosis patients.
Montes Diaz G; Fraussen J; Van Wijmeersch B; Hupperts R; Somers V
Sci Rep; 2018 May; 8(1):8194. PubMed ID: 29844361
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis.
Laroni A; Armentani E; Kerlero de Rosbo N; Ivaldi F; Marcenaro E; Sivori S; Gandhi R; Weiner HL; Moretta A; Mancardi GL; Uccelli A
J Autoimmun; 2016 Aug; 72():8-18. PubMed ID: 27157273
[TBL] [Abstract][Full Text] [Related]
15. Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.
Bielekova B; Catalfamo M; Reichert-Scrivner S; Packer A; Cerna M; Waldmann TA; McFarland H; Henkart PA; Martin R
Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5941-6. PubMed ID: 16585503
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the Impact of Daclizumab Beta on Circulating Natural Killer Cells by Mass Cytometry.
Ranganath T; Simpson LJ; Ferreira AM; Seiler C; Vendrame E; Zhao N; Fontenot JD; Holmes S; Blish CA
Front Immunol; 2020; 11():714. PubMed ID: 32391016
[TBL] [Abstract][Full Text] [Related]
17. Dimethyl fumarate activates the prostaglandin EP2 receptor and stimulates cAMP signaling in human peripheral blood mononuclear cells.
Fiedler SE; Kerns AR; Tsang C; Tsang V; Bourdette D; Salinthone S
Biochem Biophys Res Commun; 2016 Jun; 475(1):19-24. PubMed ID: 27157139
[TBL] [Abstract][Full Text] [Related]
18. Dimethyl fumarate-related immune and transcriptional signature is associated with clinical response in multiple sclerosis-treated patients.
Sánchez-Sanz A; García-Martín S; Sabín-Muñoz J; Moreno-Torres I; Elvira V; Al-Shahrour F; García-Grande A; Ramil E; Rodríguez-De la Fuente O; Brea-Álvarez B; García-Hernández R; García-Merino A; Sánchez-López AJ
Front Immunol; 2023; 14():1209923. PubMed ID: 37483622
[TBL] [Abstract][Full Text] [Related]
19. Fumaric Acid Esters Do Not Reduce Inflammatory NF-κB/p65 Nuclear Translocation, ICAM-1 Expression and T-Cell Adhesiveness of Human Brain Microvascular Endothelial Cells.
Haarmann A; Nehen M; Deiß A; Buttmann M
Int J Mol Sci; 2015 Aug; 16(8):19086-95. PubMed ID: 26287168
[TBL] [Abstract][Full Text] [Related]
20. Different Fumaric Acid Esters Elicit Distinct Pharmacologic Responses.
Wipke BT; Hoepner R; Strassburger-Krogias K; Thomas AM; Gianni D; Szak S; Brennan MS; Pistor M; Gold R; Chan A; Scannevin RH
Neurol Neuroimmunol Neuroinflamm; 2021 Mar; 8(2):. PubMed ID: 33468560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
